Literature DB >> 22967729

Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey.

Paolo Rossi1, Marta Allena, Cristina Tassorelli, Grazia Sances, Cherubino Di Lorenzo, Jessica V Faroni, Giuseppe Nappi.   

Abstract

BACKGROUND: The rate of illicit drug use in cluster headache (CH) patients is unknown.
METHODS: Two hundred and ten CH patients (162 males and 48 females) attending two headache clinics provided information about their lifetime use (once or more in their lifetime, LTU), recent use (once or more in the past year, RU), and current use (once or more in the past 30 days, CU) of illicit drugs. General population data (IPSAD®Italia2007-2008) served as the control group.
RESULTS: LTU of each illicit drug but hallucinogens, RU of cannabis, cocaine, amphetamines and ecstasy, and CU of cannabis and cocaine were significantly higher in the male CH patients than in the general population, whereas no difference was found between the CH women and the controls. In the CH group, 28.5% of patients reported having used illicit drugs for the first time after CH onset and 71.5% before CH onset. Compared with the controls, the male CH group showed a greater prevalence both of lifetime sustained intensive use of any illicit drug and of current intensive use of cannabis.
CONCLUSION: The results of this study indicate that male CH patients are prone to overindulge in illicit drug use. This finding possibly reflects a common biological susceptibility that predisposes these subjects to CH and to addictive behaviour.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22967729     DOI: 10.1177/0333102412458190

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Cocaine-induced cluster-like headache.

Authors:  Gianfranco Cafforio; Nicola Morelli; Eugenia Rota; Riccardo Mario Piane; Monica Mazzoni
Journal:  Neurol Sci       Date:  2013-09-20       Impact factor: 3.307

Review 2.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

3.  Family History of Cluster Headache: A Systematic Review.

Authors:  Maggie W Waung; Amy Taylor; Krista J Qualmann; Mark J Burish
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

Review 4.  [Update on trigeminal autonomic cephalalgia].

Authors:  C Gaul; D Holle; A May
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

5.  Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey.

Authors:  Anna Ferrari; Maurizio Zappaterra; Federica Righi; Michela Ciccarese; Ilaria Tiraferri; Luigi Alberto Pini; Simona Guerzoni; Maria Michela Cainazzo
Journal:  J Headache Pain       Date:  2013-06-06       Impact factor: 7.277

6.  The comorbidity burden of patients with cluster headache: a population-based study.

Authors:  Shivang Joshi; Paul Rizzoli; Elizabeth Loder
Journal:  J Headache Pain       Date:  2017-07-24       Impact factor: 7.277

Review 7.  Therapeutic potential of medicinal marijuana: an educational primer for health care professionals.

Authors:  Yara Mouhamed; Andrey Vishnyakov; Bessi Qorri; Manpreet Sambi; Sm Signy Frank; Catherine Nowierski; Anmol Lamba; Umrao Bhatti; Myron R Szewczuk
Journal:  Drug Healthc Patient Saf       Date:  2018-06-11

Review 8.  Pharmacotherapy for Cluster Headache.

Authors:  Roemer B Brandt; Patty G G Doesborg; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

9.  Increased use of illicit drugs in a Dutch cluster headache population.

Authors:  Ilse F de Coo; Willemijn C Naber; Leopoldine A Wilbrink; Joost Haan; Michel D Ferrari; Rolf Fronczek
Journal:  Cephalalgia       Date:  2018-10-05       Impact factor: 6.292

Review 10.  Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma.

Authors:  Grant L Iverson; Andrew J Gardner; Sandy R Shultz; Gary S Solomon; Paul McCrory; Ross Zafonte; George Perry; Lili-Naz Hazrati; C Dirk Keene; Rudolph J Castellani
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.